| dc.contributor.author | Coleman, N | |
| dc.contributor.author | Bridges, L | |
| dc.contributor.author | Saran, F | |
| dc.date.accessioned | 2018-02-15T12:19:56Z | |
| dc.date.issued | 2017-07 | |
| dc.identifier.citation | Journal of neuro-oncology, 2017, 133 (3), pp. 667 - 668 | |
| dc.identifier.issn | 0167-594X | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/1105 | |
| dc.identifier.eissn | 1573-7373 | |
| dc.identifier.doi | 10.1007/s11060-017-2483-z | |
| dc.format | Print-Electronic | |
| dc.format.extent | 667 - 668 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.subject | Humans | |
| dc.subject | Brain Neoplasms | |
| dc.subject | Multiple Sclerosis | |
| dc.subject | DNA Repair Enzymes | |
| dc.subject | DNA Modification Methylases | |
| dc.subject | Tumor Suppressor Proteins | |
| dc.subject | DNA Methylation | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Middle Aged | |
| dc.subject | Female | |
| dc.subject | Male | |
| dc.subject | Randomized Controlled Trials as Topic | |
| dc.title | MGMT promoter methylation status: time for a frank discussion. | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2017-05-15 | |
| rioxxterms.versionofrecord | 10.1007/s11060-017-2483-z | |
| rioxxterms.licenseref.startdate | 2017-07 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | Journal of neuro-oncology | |
| pubs.issue | 3 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Published | |
| pubs.volume | 133 | en_US |
| pubs.embargo.terms | Not known | |
| dc.contributor.icrauthor | Saran, Frank | en |
| dc.contributor.icrauthor | Marsden, | en |
